167 related articles for article (PubMed ID: 21869826)
1. Unrepairable DNA double-strand breaks initiate cytotoxicity with HSV-TK/ganciclovir.
Ladd B; O'Konek JJ; Ostruszka LJ; Shewach DS
Cancer Gene Ther; 2011 Oct; 18(10):751-9. PubMed ID: 21869826
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of homologous recombination with vorinostat synergistically enhances ganciclovir cytotoxicity.
Ladd B; Ackroyd JJ; Hicks JK; Canman CE; Flanagan SA; Shewach DS
DNA Repair (Amst); 2013 Dec; 12(12):1114-21. PubMed ID: 24231389
[TBL] [Abstract][Full Text] [Related]
3. Cell cycle control pathways act as conditioning factors for TK/GCV sensitivity in pancreatic cancer cells.
Abate-Daga D; Garcia-Rodríguez L; Sumoy L; Fillat C
Biochim Biophys Acta; 2010 Oct; 1803(10):1175-85. PubMed ID: 20599444
[TBL] [Abstract][Full Text] [Related]
4. Role of Equilibrative Nucleobase Transporter 1/SLC43A3 as a Ganciclovir Transporter in the Induction of Cytotoxic Effect of Ganciclovir in a Suicide Gene Therapy with Herpes Simplex Virus Thymidine Kinase.
Furukawa J; Inoue K; Ohta K; Yasujima T; Mimura Y; Yuasa H
J Pharmacol Exp Ther; 2017 Jan; 360(1):59-68. PubMed ID: 27807008
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene.
Yang L; Hwang R; Chiang Y; Gordon EM; Anderson WF; Parekh D
Clin Cancer Res; 1998 Mar; 4(3):731-41. PubMed ID: 9533543
[TBL] [Abstract][Full Text] [Related]
6. Synergistic enhancement of herpes simplex virus thymidine kinase/ganciclovir-mediated cytoxicity by hydroxyurea.
Boucher PD; Ostruszka LJ; Shewach DS
Cancer Res; 2000 Mar; 60(6):1631-6. PubMed ID: 10749133
[TBL] [Abstract][Full Text] [Related]
7. Differential chemosensitivity of breast cancer cells to ganciclovir treatment following adenovirus-mediated herpes simplex virus thymidine kinase gene transfer.
Li PX; Ngo D; Brade AM; Klamut HJ
Cancer Gene Ther; 1999; 6(2):179-90. PubMed ID: 10195885
[TBL] [Abstract][Full Text] [Related]
8. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
Tang Q; Zhang D; Wan M; Jin L
Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766
[TBL] [Abstract][Full Text] [Related]
9. Exogenous p53 and ASPP2 expression enhances rAdV-TK/ GCV-induced death in hepatocellular carcinoma cells lacking functional p53.
Liu X; Wang S; Guo X; Wei F; Yin J; Zang Y; Li N; Chen D
Oncotarget; 2016 Apr; 7(14):18896-905. PubMed ID: 26934443
[TBL] [Abstract][Full Text] [Related]
10. Generation of S phase-dependent DNA double-strand breaks by Cr(VI) exposure: involvement of ATM in Cr(VI) induction of gamma-H2AX.
Ha L; Ceryak S; Patierno SR
Carcinogenesis; 2004 Nov; 25(11):2265-74. PubMed ID: 15284180
[TBL] [Abstract][Full Text] [Related]
11. Long-circulating liposome-encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy.
Kajiwara E; Kawano K; Hattori Y; Fukushima M; Hayashi K; Maitani Y
J Control Release; 2007 Jul; 120(1-2):104-10. PubMed ID: 17509714
[TBL] [Abstract][Full Text] [Related]
12. Lead contamination results in late and slowly repairable DNA double-strand breaks and impacts upon the ATM-dependent signaling pathways.
Gastaldo J; Viau M; Bencokova Z; Joubert A; Charvet AM; Balosso J; Foray N
Toxicol Lett; 2007 Sep; 173(3):201-14. PubMed ID: 17855027
[TBL] [Abstract][Full Text] [Related]
13. Ganciclovir uptake in human mammary carcinoma cells expressing herpes simplex virus thymidine kinase.
Haberkorn U; Khazaie K; Morr I; Altmann A; Müller M; van Kaick G
Nucl Med Biol; 1998 May; 25(4):367-73. PubMed ID: 9639298
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity and accumulation of ganciclovir triphosphate in bystander cells cocultured with herpes simplex virus type 1 thymidine kinase-expressing human glioblastoma cells.
Rubsam LZ; Boucher PD; Murphy PJ; KuKuruga M; Shewach DS
Cancer Res; 1999 Feb; 59(3):669-75. PubMed ID: 9973216
[TBL] [Abstract][Full Text] [Related]
15. ATR and H2AX cooperate in maintaining genome stability under replication stress.
Chanoux RA; Yin B; Urtishak KA; Asare A; Bassing CH; Brown EJ
J Biol Chem; 2009 Feb; 284(9):5994-6003. PubMed ID: 19049966
[TBL] [Abstract][Full Text] [Related]
16. [Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation].
Xing Y; Lu G; Xiao Y; Zeng F; Zhang Q; Xiong P; Feng W
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1484-7. PubMed ID: 12509912
[TBL] [Abstract][Full Text] [Related]
17. Polyamine biosynthesis inhibition enhances HSV-1 thymidine kinase/ganciclovir-mediated cytotoxicity in tumor cells.
Pasanen T; Karppinen A; Alhonen L; Jänne J; Wahlfors J
Int J Cancer; 2003 Apr; 104(3):380-8. PubMed ID: 12569563
[TBL] [Abstract][Full Text] [Related]
18. Intravenous RMP-7 increases delivery of ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapy.
LeMay DR; Kittaka M; Gordon EM; Gray B; Stins MF; McComb JG; Jovanovic S; Tabrizi P; Weiss MH; Bartus R; Anderson WF; Zlokovic BV
Hum Gene Ther; 1998 May; 9(7):989-95. PubMed ID: 9607410
[TBL] [Abstract][Full Text] [Related]
19. Polyamine depletion and cell cycle manipulation in combination with HSV thymidine kinase/ganciclovir cancer gene therapy.
Wahlfors T; Karppinen A; Jänne J; Alhonen L; Wahlfors J
Int J Oncol; 2006 Jun; 28(6):1515-22. PubMed ID: 16685452
[TBL] [Abstract][Full Text] [Related]
20. Synergy between the herpes simplex virus tk/ganciclovir prodrug suicide system and the topoisomerase I inhibitor topotecan.
Wildner O; Blaese RM; Morris JC
Hum Gene Ther; 1999 Nov; 10(16):2679-87. PubMed ID: 10566896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
